AR and prostate carcinoma: Sialylated blood group antigen Sialyl Lewis X (SLeX) influences prostate cancer progression through various mechanisms as well as the cancer-associated sialyl-Tn glycan (sTn), which affects prostate cancer cell adhesion and whose expression is shown to be regulated by AR [99].